Laura Thomas
Adult Medicine · Virginia Beach, VANPI 1922074079
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.6% of the total across 118 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 26 manufacturers, the largest accounting for just 13.9% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $2,731 and has fallen 95.4% since, to $125 in 2025. Among adult medicine clinicians in VA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 118 payments — averaging $64.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$1K
- AstraZeneca$822
- Sanofi-aventis U.S. LLC$756
- Johnson & Johnson$680
- Lilly USA, LLC$639
- Novo Nordisk$533
- plus $3K from 20 others
What the payments were for
- Food & beverage$7,44899%
- Education$1061%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen | 14 | $1,048 |
| AstraZeneca | 17 | $822 |
| Sanofi-aventis U.S. LLC | 7 | $756 |
| Johnson & Johnson | 13 | $680 |
| Lilly USA, LLC | 16 | $639 |
| Novo Nordisk | 8 | $533 |
| Astellas Pharma US Inc | 4 | $462 |
| Bayer | 3 | $362 |
| Amarin Pharma, Inc. | 5 | $279 |
| GSK | 3 | $247 |
| AbbVie(2 entities) | 4 | $238 |
| Teva Pharmaceuticals USA, Inc. | 2 | $235 |
| Boehringer Ingelheim | 5 | $188 |
| Esperion Therapeutics, Inc. | 2 | $177 |
| Novartis | 2 | $139 |
| Kiniksa Pharmaceuticals, Ltd. | 1 | $125 |
| Regeneron Healthcare Solutions, Inc. | 1 | $125 |
| Eisai Inc. | 1 | $124 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $113 |
| Biogen | 1 | $99 |
| Biohaven Pharmaceuticals, Inc. | 1 | $53 |
| Merck | 2 | $30 |
| Mylan Specialty L.p. | 2 | $28 |
| Corcept Therapeutics | 1 | $23 |
| Pfizer | 1 | $17 |
| Boston Scientific | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$7,554 in reported general payments places this provider in the 90th percentile of 32 adult medicine providers in Virginia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 11 | $11,915 |
| Acetylcysteine | 17 | $2,086 |
| Ventolin HfaAlbuterol Sulfate | 12 | $669 |
| Metoprolol Succinate | 29 | $583 |
| Rosuvastatin Calcium | 30 | $407 |
| Atorvastatin Calcium | 34 | $339 |
| Duloxetine Hcl | 12 | $281 |
| Amlodipine Besylate | 23 | $259 |
| Levothyroxine Sodium | 13 | $192 |
| Sertraline Hcl | 15 | $180 |
| Trazodone Hcl | 12 | $163 |
| Lisinopril | 11 | $98 |
| Triamcinolone Acetonide | 11 | $38 |
| Hydrochlorothiazide | 11 | $13 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimJardiance | $188 | $11,91511 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 32 adult medicine providers in Virginia.
Other adult medicine in Virginia Beach
- Brant ThomasVirginia Beach$8K
- Melinda StoneVirginia Beach$6K
- Paul JohnstoneVirginia Beach$117
- Beth Omundsen-OttWinchester$39K
- Cindy MarrowFredericksburg$11K
- Michael TrahosSpringfield$4K
- Mariam AlimiFairfax$4K
- Janine PrimeManassas$3K
- Seema ChaudharySpringfield$2K
- Gary DavidsonAlexandria$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.